Form 4: Centene Corp Executive Kenneth Fasola Sells 8,000 Shares

Centene Corp President Kenneth J Fasola sold 8,000 shares of common stock at an average price of $77.62 on May 13, 2024.

Summary

• On May 13, 2024, Kenneth J Fasola, President of Centene Corp, sold 8,000 shares of Centene's common stock.
• The shares were sold at a weighted average price of $77.62, with individual prices ranging from $77.42 to $77.98.
• Following the transaction, Fasola directly owns 300,357 shares of Centene, which includes 243,417 shares of restricted stock units and performance stock units subject to vesting requirements.
• Fasola also holds phantom stock representing the right to receive the fair market value of 3,605.628 shares of Centene common stock, which will be settled in cash or other non-Company securities upon termination or election.

Sentiment

Score: 5

Explanation: This Form 4 filing is a neutral event. It simply reports the sale of shares by an executive, which could be for various personal financial reasons and doesn't necessarily reflect a negative outlook on the company.

Industry Context

Executive stock sales are a common occurrence and are often scrutinized by investors to gauge management's sentiment about the company's future prospects. It's important to consider the context of the sale, such as the executive's overall holdings and any pre-arranged trading plans.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, restricted stock units, and performance-based incentives.
• The prevalence of phantom stock is common in the healthcare industry, similar to companies like UnitedHealth Group (UNH) and Anthem (now Elevance Health), where executives receive deferred compensation linked to the company's stock performance.
• Monitoring insider trading activity is a standard practice, with tools available from financial data providers like Bloomberg and Refinitiv, allowing investors to compare Centene's insider activity to its peers.

Stakeholder Impact

• The sale of shares by a high-ranking executive could potentially create uncertainty among shareholders, although the impact is likely to be minimal given the relatively small number of shares sold compared to the company's overall market capitalization.

Key Dates